Organ-on-a-Chip (OoC) is a new approach for in vitro models to enhance organ/tissue physiological modeling, departing from the two-dimensional (2D) cell culture and animal models. An OoC is a microfluidic culture system that mimics the in vivo microenvironment of human organs or tissues. The micro-engineered system consists of microfluidic channels, living cells, and specialized scaffold (usually biomaterials) to simulate organ-specific functions, tissue-tissue interfaces, and dynamic factors like flow, mechanical strain, and chemical gradient in a physiological state. The most significant advantage of OoCs is that they can connect the in vitro and in vivo domains. Unlike 2D cell cultures, 3D OoCs can recreate cellular interactions, 3D architecture, and mechanical environment of native tissues.
Figure 1 Kidney-on-a-chip design.1,3
Biomaterials are the substrates used to culture cells and build tissue. Biomaterials are important in tissue engineering because they create a biomimetic microenvironment that is similar to the extracellular matrix of the native tissue. Biomimetic properties include the ability to give mechanical cues, biochemical signals, and a physical architecture that can provide cell adhesion, proliferation, differentiation, and function. For an OoC to function correctly there are a few biomimetic properties that the biomaterial should exhibit. The material should be biocompatible and ensure that it does not affect cell proliferation and activity. The material should also be able to be tuned to have mechanical properties that mimic the tissue it is trying to imitate because cells will react differently to different material stiffness. Neurons grow on softer substrates while bone cells grow on stiffer substrates. The material should also be able to give chemical cues either through material properties or surface functionalization to allow for cell-cell and cell-matrix interactions.
The selection of biomaterials for OoC applications is diverse, encompassing a range of synthetic and natural polymers, hydrogels, and composites, each offering unique properties tailored to specific organ models.
| Type of Biomaterial | Key Characteristics | Typical Advantages | Common Applications (in OoC) |
|---|---|---|---|
| Synthetic Polymers | |||
| Polydimethylsiloxane (PDMS) | Elastomeric; transparent, gas permeable, tunable stiffness. | Excellent optical clarity, easy fabrication, mechanical flexibility. | Lung-on-a-chip, intestine-on-a-chip, general microfluidic platforms. |
| Poly (lactic-co-glycolic acid) (PLGA) | Biodegradable; tunable degradation rate. | Tunable degradation, good mechanical properties, FDA-approved. | Tissue engineering scaffolds, drug development, bone-on-a-chip. |
| Natural Polymers | |||
| Collagen | Major ECM component; fibrous, promotes cell adhesion. | Natural cell-binding sites, biodegradable. | Most OoC models requiring ECM mimicry, liver-on-a-chip, skin-on-a-chip. |
| Hyaluronic Acid (HA) | Glycosaminoglycan; highly hygroscopic, biocompatible. | Non-immunogenic, highly hydrated, supports cell proliferation. | Cartilage-on-a-chip, joint-on-a-chip, neural tissue models. |
| Alginate | Polysaccharide; forms hydrogels via ionic crosslinking. | Biocompatible, tunable stiffness, non-immunogenic. | 3D cell encapsulation, bioreactors, basic organ models. |
| Hydrogels | |||
| Poly(ethylene glycol) (PEG) hydrogels | Synthetic, hydrophilic; forms hydrogels when crosslinked. | Tunable mechanical properties, inert, chemically modifiable. | General cell encapsulation, microfabrication of complex geometries. |
| Matrigel | Basement membrane extract; rich in ECM proteins. | Physiologically relevant, supports complex cell behaviors. | Tumor spheroid formation, vascularization models, general organoid culture. |
| Composites | |||
| Polymer-Ceramic Composites | Combines polymer flexibility with ceramic rigidity. | Enhanced mechanical properties, improved bioactivity. | Bone-on-a-chip, dental tissue models. |
The fabrication of biomaterials into functional OoC components involves a range of advanced microfabrication and biofabrication techniques, critical for achieving the desired multi-scale architectures and integrating cellular elements.
The field of biomaterials for Organ-on-a-Chip is evolving rapidly, driven by the increasing demand for more accurate and predictive in vitro models. Recent research progress is focusing on several key areas:
Figure 2 Representative materials used for OOC applications.2,3
Q: What are the future trends in biomaterials for Organ-on-a-Chip?
A: Emerging future directions for bio-materials are anticipated to include development of advanced composite biomaterials with finely controlled properties. Biomaterials which are able to replicate the dynamic and complex microenvironments in vivo will also become a focal point of future research. There will also be an increased interest in the interface of biomaterials with emerging technologies such as 3D bioprinting, artificial intelligence and machine learning.
Q: How do I ensure the biocompatibility of a new biomaterial for Organ-on-a-Chip?
A: Biocompatibility may be assessed in vitro by cell viability assays, cytotoxicity tests, and cell-adhesion studies. In vivo, animal models may be used to assess the biocompatibility of a new biomaterial by implanting the new biomaterial and observing any negative responses. Alternatively, comparison of the new biomaterial's properties and performance to well-established biocompatible materials can also be used to estimate the biocompatibility of the new material.
Q: Why are mechanical properties of biomaterials important in OoC modeling?
A: Mechanical properties (stiffness, elasticity, and viscoelasticity) are important because cells are highly mechanosensitive and respond to the physical properties of their environment (e.g., cell fate, cell migration, cell differentiation, and tissue organization). Biomaterials with tunable mechanical properties (e.g., crosslinking density in hydrogels) enable researchers to match the mechanical microenvironment of native tissues and thereby elicit the desired cellular response.
At Creative Biolabs, we are at the forefront of advancing Organ-on-a-Chip technology through our comprehensive range of services and resources dedicated to biomaterials and OoC development. Leveraging our deep expertise in biomaterial science, tissue engineering, and microfluidics, we offer:
Creative Biolabs provides researchers with the tools and know-how to fully realize the potential of Organ-on-a-Chip technologies, ultimately enabling more effective drug candidates and a deeper understanding of human biology and disease. Contact us today to learn more!
References